A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
for Ovarian Cancer
Drug: Bevacizumab
5 locations incl. Denver
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07278336·Phase 1·Recruiting